IPA

Geneva, 20 September 2019

This revision is subject to a focused stakeholder consultation which includes both consultation questions and an opportunity to comment on:

    –    a draft Annex 2A (PS/INF 25/2019 (Rev. 1)): Manufacture of Advanced Therapy Medicinal Products for Human Use; and
    –    a draft Annex 2B (PS/INF 26/2019 (Rev. 1)): Manufacture of Biological Medicinal Substances and Products for Human Use. 

For more details: https://picscheme.org/en/news/22/-revision-of-pic-s-gmp-guide